We are live on
!
Find out more
CC
Caxton Corporation Portfolio holdings
AUM
$4.02M
1-Year Est. Return
256.08%
This Fund
S&P 500
This Quarter
Est. Return
+26.41%
1 Year Est. Return
+256.08%
3 Year Est. Return
+777.99%
5 Year Est. Return
+744.68%
10 Year Est. Return
+18,621.85%
AUM
$149M
AUM Growth
+$31.1M
(+26%)
Cap. Flow
-$39K
Cap. Flow
% of AUM
-0.03%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
2
New
–
Increased
1
Reduced
1
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Madrigal Pharmaceuticals
MDGL
|
+$15.1K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HALL
Hallmark Financial Services, Inc.
HALL
|
+$54.1K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 99.87% |
| 2 | Financials | 0.13% |
Similar funds
PCM
EAMS
RCP
RA
CGA
HFA
ABA
UOMF
Caxton Corporation's Q3 2013 Portfolio in Review
As of Q3 2013, Caxton Corporation held 2 positions worth $149M, up 26% from $118M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Trading was light in Q3 2013: portfolio turnover was 0%. Caxton Corporation opened no new positions and made no exits, leaving the 2-position portfolio largely intact.
By sector, the portfolio is most concentrated in Healthcare at 100% of assets, up from 100% a quarter earlier, followed by Financials.
- Caxton Corporation added most to Madrigal Pharmaceuticals in Q3 2013, an estimated $15.1K increase.
- Caxton Corporation's biggest Q3 2013 reduction was Hallmark Financial Services, Inc., cutting an estimated $54.1K.
- Caxton Corporation's ten largest holdings make up 100% of its $149M portfolio in Q3 2013.
- Caxton Corporation opened 0 new positions and closed 0 in Q3 2013.
- Caxton Corporation's portfolio value rose 26% quarter-over-quarter to $149M.
Based on Caxton Corporation's 13F filing for Q3 2013, filed 14 Nov 2013.